The firm raised its rating to buy and target price to imply gains of nearly 23% ahead.
You are here: Home / This Johnson & Johnson spin-off could rally more than 20%, Goldman Sachs predicts
Market News and Views
The firm raised its rating to buy and target price to imply gains of nearly 23% ahead.